Vimarsana
Biggest News Aggregation in the World

Page 18 - Excellence Framework News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Excellence Framework. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Excellence Framework Today - Breaking & Trending Today

Rare VEXAS disease affecting only men is found to be more common than first thought - Vimarsana News

Rare VEXAS disease affecting only men is found to be more common than first thought

 E-Mail A rare disease first identified in 2020 is much more common than first thought, say researchers at the University of Leeds investigating its origins. VEXAS syndrome is a serious inflammatory condition which develops in men over 50, causing them to become very sick and fatigued, and can be fatal. It was originally thought to be rare, but a new study has identified genetic mutations which indicate that the disease is actually much more common. The researchers developed a genetic test to identify patients who may have the disease, and now want to screen more people showing symptoms to...

Scientists find strongest evidence yet of 'migration gene' - Vimarsana News

Scientists find strongest evidence yet of 'migration gene'

Credit: Andrew Dixon A team from the Chinese Academy of Sciences and Cardiff University say they have found the strongest evidence yet of a "migration gene" in birds. The team identified a single gene associated with migration in peregrine falcons by tracking them via satellite technology and combining this with genome sequencing. They say their findings add further evidence to suggest genetics has a strong role to play in the distance of migration routes. The study, published today in the journal Nature, also looks at the predicted effect of climate change on migration - and how this might ...

Energy switching decisions could widen social inequalities - Vimarsana News

Energy switching decisions could widen social inequalities

Credit: Piqsels (creative commons) New energy tariffs could leave people on bad deals even worse off despite the potential benefits for everyone, research has found. The study, led by the University of Leeds, found new types of energy contracts designed for a low carbon future could benefit all types of customer, with opportunities to sell excess energy from solar panels or incentives for using energy at off-peak times. However, many people were unlikely to choose them because they were disengaged from the energy market, didn't trust energy companies, or already feel satisfied with their cu...

Genetic study uncovers hidden pieces of?eye disease?puzzle? - Vimarsana News

Genetic study uncovers hidden pieces of?eye disease?puzzle?

Credit: Community Eye Health (Flickr) Scientists have taken a significant step forward in their search for the origin of a progressive eye condition which causes sight loss and can lead to corneal transplant. A new study into keratoconus by an international team of researchers, including a University of Leeds group led by Chris Inglehearn, Professor of Molecular Ophthalmology in the School of Medicine, has for the first time detected DNA variations which could provide clues as to how the disease develops. Keratoconus causes the cornea, which is?the clear outer layer?at the front of the eye,...

Pure Transplant Solutions and King's College London to Support Clinical Trial for HLA Sensitized Patients with End Stage Renal Disease - Vimarsana News

Pure Transplant Solutions and King's College London to Support Clinical Trial for HLA Sensitized Patients with End Stage Renal Disease

AUSTIN, Texas /Massachusetts Newswire – National News/ — Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with King’s College London, a leading university providing world-class teaching and cutting-edge research, to support the Phase IIa GAMECHANgER-1 clinical trial. The trial aims to determine whether adoptive transfer of regulatory T cells (Tregs) in...